Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Pulmonary Medicine

Infectious, Rare and Idiopathic Pulmonary Diseases

Section edited by Sanjay Chotirmall and Giovanni Sotgiu

This section concerns all aspects of pulmonary infection, rare and idiopathic lung diseases including, but not limited to: prevention, diagnosis and management, as well as related molecular genetics, and pathophysiology.

Previous Page Page 1 of 10 Next Page
  1. Content type: Research article

    Dyspnea is the hallmark symptom of pulmonary fibrosis. Supplemental oxygen (O2) is prescribed to many patients with pulmonary fibrosis in hopes of alleviating dyspnea and improving physical functioning. We used r...

    Authors: Amy L. Olson, Bridget Graney, Susan Baird, Tara Churney, Kaitlin Fier, Marjorie Korn, Mark McCormick, David Sprunger, Thomas Vierzba, Frederick S. Wamboldt and Jeffrey J. Swigris

    Citation: BMC Pulmonary Medicine 2017 17:152

    Published on:

  2. Content type: Research article

    The incidence of tuberculosis (TB) is high among human immunodeficiency virus (HIV) infected Ugandans. Recent evidence suggests that Chronic Pulmonary Aspergillosis and Aspergillus sensitisation might be responsi...

    Authors: Richard Kwizera, Rosalind Parkes-Ratanshi, Iain D. Page, Christine Sekaggya-Wiltshire, Joseph Musaazi, Jan Fehr, Barbara Castelnuovo, Andrew Kambugu and David W. Denning

    Citation: BMC Pulmonary Medicine 2017 17:149

    Published on:

  3. Content type: Research article

    This study aimed to investigate clinical characteristics of Korean PAP patients and to examine the potential risk factors of PAP.

    Authors: Ji An Hwang, Joo Han Song, Jung Hoon Kim, Man Pyo Chung, Dong Soon Kim, Jin Woo Song, Young Whan Kim, Sun Mi Choi, Seung Ick Cha, Soo Taek Uh, Choon-Sik Park, Sung Hwan Jeong, Yong Bum Park, Hong Lyeol Lee, Jong Wook Shin, Eun Joo Lee…

    Citation: BMC Pulmonary Medicine 2017 17:147

    Published on:

  4. Content type: Research article

    Clinical guidelines specify that diagnosis of interstitial pulmonary fibrosis (IPF) requires identification of usual interstitial pneumonia (UIP) pattern. While UIP can be identified by high resolution CT of t...

    Authors: Yoonha Choi, Jiayi Lu, Zhanzhi Hu, Daniel G. Pankratz, Huimin Jiang, Manqiu Cao, Cristina Marchisano, Jennifer Huiras, Grazyna Fedorowicz, Mei G. Wong, Jessica R. Anderson, Edward Y. Tom, Joshua Babiarz, Urooj Imtiaz, Neil M. Barth, P. Sean Walsh…

    Citation: BMC Pulmonary Medicine 2017 17:141

    Published on:

  5. Content type: Research article

    Pulmonary exacerbations in cystic fibrosis (CF) remain poorly understood and treatment is usually targeted at Pseudomonas aeruginosa. Within Australia a predominant shared P. aeruginosa strain (AUST-02) is associ...

    Authors: Anna S. Tai, Laura J. Sherrard, Timothy J. Kidd, Kay A. Ramsay, Cameron Buckley, Melanie Syrmis, Keith Grimwood, Scott C. Bell and David M. Whiley

    Citation: BMC Pulmonary Medicine 2017 17:138

    Published on:

  6. Content type: Research article

    Clinical characteristics and the prognostic significance of changes in mean platelet volume (MPV) during hospitalization for community-acquired pneumonia (CAP) have not been investigated.

    Authors: Oleg Gorelik, Irma Tzur, Dana Barchel, Dorit Almoznino-Sarafian, Muhareb Swarka, Ilia Beberashvili, Leonid Feldman, Natan Cohen and Shimon Izhakian

    Citation: BMC Pulmonary Medicine 2017 17:137

    Published on:

  7. Content type: Case report

    In this report, we describe the first successful case of transition from subcutaneous administration of treprostinil to selexipag in a patient with severe pulmonary arterial hypertension (PAH), by evaluating h...

    Authors: Asuka Furukawa, Yuichi Tamura, Hiroya Iwahori, Masato Goto, Narutaka Ohashi, Teruo Okabe and Akio Kawamura

    Citation: BMC Pulmonary Medicine 2017 17:135

    Published on:

  8. Content type: Research article

    Rapidly progressive interstitial pneumonias (RPIPs) associated with clinically amyopathic dermatomyositis (CADM) are highly resistant to therapy and have a poor prognosis. Multimodal therapies, including direc...

    Authors: Hiroko Okabayashi, Hidenori Ichiyasu, Sayuri Hirooka, Kimitaka Akaike, Keisuke Kojima, Takayuki Jodai, Yasumiko Sakamoto, Hideharu Ideguchi, Shohei Hamada, Chieko Yoshida, Susumu Hirosako, Shinichiro Okamoto and Hirotsugu Kohrogi

    Citation: BMC Pulmonary Medicine 2017 17:134

    Published on:

  9. Content type: Research article

    Idiopathic Pulmonary Fibrosis (IPF) is a fatal fibrotic lung disease occurring predominantly in middle-aged and older adults. The traditional diagnostic classification of IPF is based on clinical, radiological...

    Authors: Yunguan Wang, Jaswanth Yella, Jing Chen, Francis X. McCormack, Satish K. Madala and Anil G. Jegga

    Citation: BMC Pulmonary Medicine 2017 17:133

    Published on:

  10. Content type: Research article

    Recent evidences show that Pulmonary Rehabilitation (PR) is effective in patients with Interstitial Lung Disease (ILD). It is still unclear whether disease severity and/or etiology might impact on the reported...

    Authors: Roberto Tonelli, Elisabetta Cocconcelli, Barbara Lanini, Isabella Romagnoli, Fabio Florini, Ivana Castaniere, Dario Andrisani, Stefania Cerri, Fabrizio Luppi, Riccardo Fantini, Alessandro Marchioni, Bianca Beghè, Francesco Gigliotti and Enrico M. Clini

    Citation: BMC Pulmonary Medicine 2017 17:130

    Published on:

  11. Content type: Research article

    Two antifibrotic drugs, pirfenidone and nintedanib, are approved by the European Medicines Agency and the US Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis (IPF). In this analy...

    Authors: Toby M. Maher, Maria Molina-Molina, Anne-Marie Russell, Francesco Bonella, Stéphane Jouneau, Elena Ripamonti, Judit Axmann and Carlo Vancheri

    Citation: BMC Pulmonary Medicine 2017 17:124

    Published on:

  12. Content type: Research article

    Late-onset noninfectious pulmonary complications (LONIPCs), which occur more than 3 months after allogeneic hematopoietic stem cell transplantation (HSCT), are major causes of morbidity and mortality after tra...

    Authors: Ho Namkoong, Makoto Ishii, Takehiko Mori, Hiroaki Sugiura, Sadatomo Tasaka, Masatoshi Sakurai, Yuya Koda, Jun Kato, Naoki Hasegawa, Shinichiro Okamoto and Tomoko Betsuyaku

    Citation: BMC Pulmonary Medicine 2017 17:123

    Published on:

  13. Content type: Study protocol

    Pirfenidone is currently approved in the EU for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) and offers a beneficial risk-benefit profile. However, there are several other, progressive...

    Authors: Jürgen Behr, Petra Neuser, Antje Prasse, Michael Kreuter, Klaus Rabe, Carmen Schade-Brittinger, Jasmin Wagner and Andreas Günther

    Citation: BMC Pulmonary Medicine 2017 17:122

    Published on:

  14. Content type: Research article

    To identify the prognostic factors for survival in patients with interstitial pneumonia with autoimmune features (IPAF) who meet the serological domain of the IPAF criteria.

    Authors: Yuhei Ito, Machiko Arita, Shogo Kumagai, Reoto Takei, Maki Noyama, Fumiaki Tokioka, Keisuke Nishimura, Takashi Koyama, Kenji Notohara and Tadashi Ishida

    Citation: BMC Pulmonary Medicine 2017 17:111

    Published on:

  15. Content type: Case report

    Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome, lymphangioleiomyomatosis/tuberous sclerosis complex (LAM-TSC), and sarcoidosis are three rare diseases. Here we present, to the best of our know...

    Authors: Fabiano Di Marco, Giuseppina Palumbo, Silvia Terraneo, Gianluca Imeri, Elena Lesma, Nicola Sverzellati, Angela Peron, Lorenzo Gualandri, Maria Paola Canevini and Stefano Centanni

    Citation: BMC Pulmonary Medicine 2017 17:107

    Published on:

  16. Content type: Research article

    Physical activity (PA) is associated with disease severity in idiopathic pulmonary fibrosis (IPF), but longitudinal studies evaluating its prognostic value and changes over time are lacking.

    Authors: Thomas Bahmer, Anne-Marie Kirsten, Benjamin Waschki, Klaus F. Rabe, Helgo Magnussen, Detlef Kirsten, Marco Gramm, Simone Hummler, Eva Brunnemer, Michael Kreuter and Henrik Watz

    Citation: BMC Pulmonary Medicine 2017 17:104

    Published on:

  17. Content type: Research article

    The role of CD4+CD25highCD127 T-reg cells in solid-organ Transplant (Tx) acceptance has been extensively studied. In previous studies on kidney and liver recipients, peripheral T-reg cell counts were associated ...

    Authors: Davide Piloni, Monica Morosini, Sara Magni, Alice Balderacchi, Luigia Scudeller, Emanuela Cova, Tiberio Oggionni, Giulia Stella, Carmine Tinelli, Filippo Antonacci, Andrea Maria D’Armini and Federica Meloni

    Citation: BMC Pulmonary Medicine 2017 17:102

    Published on:

  18. Content type: Case report

    Burkholderia cepacia complex is a group of opportunistic pathogens in cystic fibrosis (CF) patients believed to be associated with poor prognosis and patient-to-patient transmissibilit...

    Authors: Cassiana da Costa Ferreira Leite, Tania Wrobel Folescu, Mônica de Cássia Firmida, Renata Wrobel Folescu Cohen, Robson Souza Leão, Flávia Alvim Dutra de Freitas, Rodolpho Mattos Albano, Claudia Henrique da Costa and Elizabeth Andrade Marques

    Citation: BMC Pulmonary Medicine 2017 17:100

    Published on:

  19. Content type: Research article

    Bloodstream pathogens can be identified by multiplex PCR (SeptiFast (SF)) or blood culture (BC); whether these pathogens are present in cystic fibrosis (CF) patients during febrile pulmonary exacerbations (FPE...

    Authors: Joerg Grosse-Onnebrink, Florian Stehling, Eva Tschiedel, Margarete Olivier, Uwe Mellies, Rene Schmidt, Jan Buer, Peter-Micheal Rath and Joerg Steinmann

    Citation: BMC Pulmonary Medicine 2017 17:96

    Published on:

Previous Page Page 1 of 10 Next Page